Skip to main content
SpringerLink
Log in

HTA appraisals on CAR-T therapies in Europe

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Macaulay R, et al. Will CAR-T Cell Therapies Change How Drugs Are Priced and Reimbursed? 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PCN196, 18 May 2019.

  2. Macaulay R, et al. Putting the CAR-T Before the Horse- Have ATMPs Emerged Before Coherent Reimbursement Processes Have Been Established? 24th Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research : (plus poster) abstr. PBI32, 18 May 2019.

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

HTA appraisals on CAR-T therapies in Europe. PharmacoEcon Outcomes News 830, 17 (2019). https://doi.org/10.1007/s40274-019-5968-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5968-5

Search

Navigation